Literature DB >> 10723051

Regional localization of dopamine and ionotropic glutamate receptor subtypes in striatolimbic brain regions.

F I Tarazi1, R J Baldessarini.   

Abstract

Localization of dopamine (D(1)-, D(2)-like, and D(4)) and ionotropic glutamate (NMDA, AMPA, and KA) receptor subtypes within the striatolimbic forebrain remains incomplete, but basic to understanding the functional organization of this important brain region. We found that frontal cortical ablation supported colocalization of D(4) and NMDA receptors on corticostriatal afferents to caudate-putamen and nucleus accumbens in rat forebrain. Local injection of kainic acid into caudate-putamen, nucleus accumbens, or hippocampus produced massive local postsynaptic losses of D(1)- and D(2)-like, as well as NMDA, AMPA, and KA receptors, and kainic acid ablation of hippocampal-striatal projections indicated the selective expression of presynaptic NMDA and KA autoreceptors. Degeneration of nigrostriatal dopamine projections with 6-hydroxydopamine showed that all three glutamatergic subtypes exist as heteroceptors on nigrostriatal dopaminergic terminals. Our findings suggest common interactions between excitatory glutamatergic and inhibitory dopaminergic receptors in rat forebrain. Further localization of these receptor subtypes in striatolimbic forebrain should help to clarify their contributions to the pathophysiology of neuropsychiatric disorders and their treatment. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10723051     DOI: 10.1002/(SICI)1097-4547(19990215)55:4<401::AID-JNR1>3.0.CO;2-H

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  12 in total

1.  Dopaminergic modulation of prefrontal cortical input to nucleus accumbens neurons in vivo.

Authors:  Anne Marie Brady; Patricio O'Donnell
Journal:  J Neurosci       Date:  2004-02-04       Impact factor: 6.167

2.  When administered into the nucleus accumbens core or shell, the NMDA receptor antagonist AP-5 reinstates cocaine-seeking behavior in the rat.

Authors:  Katie R Famous; Heath D Schmidt; R Christopher Pierce
Journal:  Neurosci Lett       Date:  2007-05-03       Impact factor: 3.046

3.  Neuropharmacology of dopamine receptors:: Implications in neuropsychiatric diseases.

Authors:  F I Tarazi
Journal:  J Sci Res Med Sci       Date:  2001-10

Review 4.  Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addiction.

Authors:  Heath D Schmidt; R Christopher Pierce
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

Review 5.  Calcium-dependent networks in dopamine-glutamate interaction: the role of postsynaptic scaffolding proteins.

Authors:  Andrea de Bartolomeis; Carmine Tomasetti
Journal:  Mol Neurobiol       Date:  2012-07-05       Impact factor: 5.590

Review 6.  Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans.

Authors:  Mireille Basselin; Epolia Ramadan; Stanley I Rapoport
Journal:  Brain Res Bull       Date:  2011-12-09       Impact factor: 4.077

Review 7.  Ethanol-Associated Changes in Glutamate Reward Neurocircuitry: A Minireview of Clinical and Preclinical Genetic Findings.

Authors:  Richard L Bell; Sheketha R Hauser; Jeanette McClintick; Shafiqur Rahman; Howard J Edenberg; Karen K Szumlinski; William J McBride
Journal:  Prog Mol Biol Transl Sci       Date:  2015-11-24       Impact factor: 3.622

8.  Basolateral amygdala modulates terminal dopamine release in the nucleus accumbens and conditioned responding.

Authors:  Joshua L Jones; Jeremy J Day; Brandon J Aragona; Robert A Wheeler; R Mark Wightman; Regina M Carelli
Journal:  Biol Psychiatry       Date:  2009-12-30       Impact factor: 13.382

9.  Chronic carbamazepine administration attenuates dopamine D2-like receptor-initiated signaling via arachidonic acid in rat brain.

Authors:  Mireille Basselin; Lisa Chang; Mei Chen; Jane M Bell; Stanley I Rapoport
Journal:  Neurochem Res       Date:  2008-02-27       Impact factor: 3.996

Review 10.  Bipolar disorder and mechanisms of action of mood stabilizers.

Authors:  Stanley I Rapoport; Mireille Basselin; Hyung-Wook Kim; Jagadeesh S Rao
Journal:  Brain Res Rev       Date:  2009-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.